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To the Editor: Legionella 
pneumophila serogroups (SGs) 1–16 
cause pneumonia in humans. Although 
SG 1 is the serogroup most commonly 
associated with disease (1), we 
report a case of community-acquired 
legionellosis caused by SG 11.
In November 2010, a 42-year-
old man was admitted to Modena 
University Hospital, Modena, Italy, 
with a 4-day history of fever, dyspnea, 
and cough. His vital signs were as 
follows: temperature 40.0°C, pulse 135 
beats/min, blood pressure 110/60 mm 
Hg, respiratory rate 30 breaths/min, 
and oxygen saturation 85% in room air. 
Inspiratory crackles were heard in the 
left lower lung lobe. Chest radiographs 
and successive high-resolution 
computerized tomography revealed left 
lobar infi ltrates (Figure, panels A and 
B). Blood count documented severe 
pancytopenia together with high levels 
of infl ammation markers: fi brinogen 
(1,031 mg/dL), C-reactive protein (33 
mg/dL), and procalcitonin (28.5 ng/
mL). The patient’s medical history 
was unremarkable; however, results of 
tests conducted at the time of hospital 
admission led to the diagnosis of acute 
leukemia.
Empirically prescribed antimicro-
bial treatment for neutropenic 
patients was initiated and consisted of 
meropenem (3 g/day) and levofl oxacin 
(500 mg/day), combined fi rst with 
vancomycin (2 g/day) and later with 
linezolid (1,200 mg/day). A few 
days later, antifungal therapy was 
empirically added to the treatment 
regimen (liposomal amphotericin B 
at 3 mg/kg/day). The patient received 
continuous positive airway pressure, 
which resulted in progressive 
improvement of blood gas exchange, 
until normalization was achieved.
Serologic and molecular exam-
ination and culture of bronchoalveolar 
lavage fl uid, blood, urine, and feces 
produced negative results for fungal, 
viral, and bacterial pathogens. Test 
results for L. pneumophila urinary 
antigen (Biotest AG, Dreieich, 
Germany) and IgM and IgG 
against L. pneumophila (Serion-
Immundiagnostica GmbH, Würzburg, 
Germany) were negative. Culture 
of sputum collected at the time of 
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Figure. Imaging studies of 42-year-old man with severe pneumonia caused by Legionella 
pneumophila serogroup 11, showing lobar consolidation of the left lower lung lobe, with 
an air-bronchogram within the homogeneous airspace consolidation. Consensual mild 
pleural effusion was documented by a chest radiograph (A) and high-resolution computed 
tomography (B). A week after hospital admission, repeat high-resolution computerized 
tomography of the chest showed extensive and homogeneous consolidation of left upper 
and lower lobes, accompanied by bilateral ground-glass opacities (C and D).
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hospital admission showed growth of 
legionella-like colonies on buffered 
charcoal yeast extract, with and 
without the addition of antimicrobial 
drugs (Oxoid, Basingstoke, UK). 
The colonies were identifi ed as 
L. pneumophila SGs 2–14 by the 
Legionella latex test (Oxoid). The 
strain was further characterized as 
L. pneumophila SG 11, according 
to a polyclonal latex reagent set 
(Biolife, Milan, Italy). Environmental 
investigations were conducted in the 
patient’s house and workplace, but L. 
pneumophila SG 11 was not detected 
in any of the locations tested.
A week after hospital admission, 
the patient was persistently febrile and 
experienced pain in the left thorax. High-
resolution computerized tomography 
of the chest was repeated and showed 
increased pulmonary infi ltrate (Figure, 
panels C and D) that was consistent 
with L. pneumophila pneumonia 
(2). Highly potent antimicrobial 
therapy against L. pneumophila 
was administered, consisting of 
high-dosage levofl oxacin (1 g/day) 
combined with azithromycin (500 mg/
day), while the other antimicrobial 
agents were progressively reduced (3). 
The fever subsided 14 days after the 
onset of targeted antimicrobial drug 
treatment; at that time, the sputum 
culture and test results for urinary L. 
pneumophila antigen were negative, 
but serologic assay results were 
positive for IgG and negative for IgM 
against L. pneumophila. Subsequent 
computerized tomographic scans of 
the chest documented progressive 
improvement of lung infi ltrates, 
and nearly complete resolution was 
obtained 3 months after hospital 
admission.
L. pneumophila SG 11 infection 
has, thus far, been reported only rarely 
in humans. The fi rst SG 11 strain was 
isolated in the United States in 1982 
from a patient with multiple myeloma 
(4). Since then, few other cases of 
SG 11 strains have been reported in 
Europe (5,6); it is conceivable that 
this strain is not as widely distributed 
and is less pathogenic than other SGs, 
especially SG 1. It can be argued that 
infections caused by SG 11 have been 
underdiagnosed. L. pneumophila SG 
11 cannot be detected by Legionella 
urinary antigen or serologic tests, 
the assays most frequently used to 
diagnose legionellosis (7–9). The 
negative urinary antigen test result for 
this patient is consistent with a non–
SG 1 infection. The single positive 
serologic result for IgG was probably 
caused by cross-reactivity because the 
commercial assay kit was designed 
to recognize only L. pneumophila 
SGs 1–7. Culture is the only useful 
diagnostic tool for identifying SGs. 
However, this tool is not always 
feasible because it requires specialized 
media and skills to identify the 
organism. In addition, sensitivity is 
low, depending on the severity of the 
disease and the availability of adequate 
respiratory specimens (9). Despite 
these limitations, culture is needed 
to detect all SGs of L. pneumophila, 
especially in immunocompromised 
patients, who are more susceptible to 
infections caused by strains of non–
SG 1 L. pneumophila (10).
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To the Editor: Human 
enteroviruses (HEVs) are small, 
nonenveloped viruses with a positive-
stranded RNA genome that includes 
regions P1, P2, and P3 (1). Most 
experts believe that HEV strains 
with >75% nt and >85% aa identity 
in complete or partial viral protein 1 
(VP1) sequences should be considered 
the same type (2). However, more 
stringent criteria of 75% nt and 88% 
aa identity have been suggested for 
routine typing (3). We report the 
isolation  and characterization of a 
novel HEV type within the species 
HEV-C (designated EV-C117 by the 
Picornaviridae Study Group, www.
picornastudygroup.com/).
A 45-month-old boy was admitted 
to a hospital in Vilnius, Lithuania, in 
December 2010 after 1 day of high 
fever (temperature 40°C) with cough 
and a moderately increased respiratory 
rate (36 breaths/min). Decreased 
breath sounds were heard at the base of 
the left lung during auscultation, and 
a chest radiograph showed alveolar 
pneumonia with partial consolidation 
of the lower lobe of the left lung. The 
patient had a leukocyte count of 23,900 
cells/mm3 and C-reactive protein 
level of 9.6 mg/dL. Blood culture 
results were negative for bacteria and 
fungi. The patient was treated with 
cefuroxime (500 mg every 8 h) for 7 
days. Oxygen administration was not 
required because the saturation level of 
peripheral oxygen was always >97%. 
The patient was discharged in good 
clinical condition after 7 days and did 
not experience clinical problems in the 
following 4 weeks.
For research purposes, a 
nasopharyngeal sample was collected 
from the boy at hospital admission 
by using a fl exible pernasal fl ocked 
swab; written informed consent was 
obtained from the parents. The swab 
was immediately placed in a minitube 
containing 1 mL of universal transport 
medium (UTM-RT Kit; Copan Italia, 
Brescia, Italy). The sample was stored 
at 4°C in the hospital laboratory 
before being sent to the central 
laboratory at the University of Milan, 
Italy in a refrigerated package. We 
extracted viral nucleic acids from the 
swab sample by using an automated 
extraction system (NucliSens 
easyMAG; Biomeriéux, Craponne, 
France), and we tested the extract 
for respiratory viruses by using the 
Respiratory Virus Panel ( Fast assay 
(Luminex Molecular Diagnostics 
Inc., Toronto, Ontario, Canada) in 
accordance with the manufacturer’s 
instructions (4).
The assay result was positive for 
bocavirus and enterovirus/rhinovirus, 
so we retested the sample to identify 
the rhinovirus. We performed real-
time reverse transcription PCR by 
using the AgPath-ID One-Step RT-
PCR Kit (Applied Biosystems, Foster 
City, CA, USA) and primers and 
probe sequences reported by Lu et 
al. (5). Phylogenetic analysis of the 
VP4/VP2 region showed that some 
nucleotide sequences belonged to 
enterovirus species. We obtained 
a partial VP1 sequence by using 
the primers described by Nix et al. 
(6), and we obtained the remaining 
sequence of the VP1 capsid region 
by using in-house amplifi cation and 
sequencing protocols (available upon 
request). The complete P1 sequence 
was submitted to the Picornaviridae 
Study Group, compared with other 
enterovirus sequences, and designated 
as a proposed new type of enterovirus, 
EV-C117 (GenBank accession no. 
JQ446368).
To obtain additional viral 
sequences, we analyzed and 
sequenced the complete P1 capsid 
region. This region was compared 
with the matching region of all of 
the complete enterovirus genomes 
available in the GenBank database 
(as of January 20, 2012). On the 
basis of the nucleotide sequences, we 
reconstructed a phylogenetic tree by 
using maximum likelihood methods 
with the Tamura 3-parameter model as 
the evolutionary model; rates among 
sites were heterogeneous, and gamma 
distribution was used for the relative 
rate (7). The closest genotypes were 
EV-C104 (GenBank accession no. 
EU840733) and EV-C109 (GenBank 
accession no. NC014336) (Figure). 
The VP4 genomic region had the 
greatest identity with other HEV 
strains; the VP1 coding region had the 
lowest identity.
We report the identifi cation of 
a novel enterovirus (designated EV-
C117) in a child hospitalized with 
community-acquired pneumonia in 
Vilnius, Lithuania. EV-C117 was 
detected in the child in association 
with bocavirus. Although it is not 
possible to say whether this new 
enterovirus was the etiologic cause 
of the disease, a close relationship 
has been found (mainly in children) 
between the development of severe 
lower respiratory tract infections 
requiring hospitalization and 
infections caused by EV-68 (8) and 
EV-C104 and EV-C109 (9), which 
are molecularly similar to EV-C117. 
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